Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

SGX:T14

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is T14's stock price target?

Not Available

T14 doesn't have any price targets made by Wall Street professionals.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Revenue forecast?

Projected CAGR

-2%

For the last 13 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's revenue is 4%. The projected CAGR for the next 3 years is -2%.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Operating Income forecast?

Projected CAGR

45%

For the last 13 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's operating income is 9%. The projected CAGR for the next 2 years is 45%.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Net Income forecast?

Projected CAGR

-16%

For the last 13 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's net income is 18%. The projected CAGR for the next 3 years is -16%.